COSENTYX 25 mg/mL (Secukinumab INJECTION, SOLUTION, CONCENTRATE) 25 mg/mL

COSENTYX 25 mg/mL is a prescription medication used for managing specific inflammatory conditions. This injectable solution is designed to target underlying causes of symptoms, offering a potential solution for long-term management.

Strength

25 mg/mL

Pack Size

5 mL in 1 VIAL, GLASS (0078-1168-61)

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

COSENTYX 25 mg/mL is primarily used for the treatment of moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. This medication works by targeting specific proteins involved in the inflammatory process, helping to reduce symptoms and improve quality of life. Patients often wonder, 'what is COSENTYX used for?' and the answer lies in its ability to manage chronic inflammatory conditions effectively.

Side Effects

Common effects of COSENTYX 25 mg/mL may include reactions at the injection site, such as redness, itching, or swelling. Some users might experience headaches, fatigue, or upper respiratory infections. These effects vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

COSENTYX 25 mg/mL should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed guidelines for use and to inform healthcare providers of any existing medical conditions or allergies. This medication is intended for intravenous use and should be administered by a healthcare professional.

Avoid Interactions

COSENTYX 25 mg/mL may interact with certain medications, including those that affect the immune system. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also influence the effectiveness or safety of this medication.

Frequently Asked Questions

COSENTYX 25 mg/mL is used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis by targeting specific proteins involved in inflammation.

COSENTYX 25 mg/mL is administered intravenously by a healthcare professional. It is important to follow the prescribed guidelines for proper administration.

Common side effects may include injection site reactions, headaches, fatigue, and upper respiratory infections. These effects vary among individuals.

COSENTYX 25 mg/mL may interact with certain medications, especially those affecting the immune system. Always consult a healthcare provider before combining medications.

COSENTYX 25 mg/mL should be stored according to the manufacturer's guidelines to maintain its effectiveness and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.